Current State of Minitablet Product Design: A Review

S Meruva, AB Singaraju, BP Vinjamuri, R Ternik… - Journal of …, 2024 - Elsevier
Interest in minitablets (MTs) has grown exponentially over the last 20 years and especially
the last decade, as evidenced by the number of publications cited in Scopus and PubMed …

Recent Advances in Dissolution Testing and Their Use to Improve In Vitro–In Vivo Correlations in Oral Drug Formulations

A Ranjan, PK Jha - Journal of Pharmaceutical Innovation, 2022 - Springer
Bioavailability of oral drug formulations is strongly dependent on the composition of the
gastric and intestinal fluids and hydrodynamic conditions in the gastrointestinal tract. These …

Mini-tablets versus nanoparticles for controlling the release of amoxicillin: In vitro/in vivo study

DA Gaber, HS Alhawas, FA Alfadhel… - Drug design …, 2020 - Taylor & Francis
Introduction Controlling the drug release from the dosage form at a definite rate is the main
challenge for a successful oral controlled-release drug delivery system. In this study, mini …

Formulation of Tablets in Capsule system: Statistical optimization for chronotherapeutic drug delivery of propranolol hydrochloride

B Gowthami, SVG Krishna, DS Rao - Journal of Drug Delivery Science and …, 2021 - Elsevier
Chronic diseases like asthma, hypertension and rheumatoid arthritis requires prompt
release of drug as per the disease condition. Conversely, extended release systems can …

[HTML][HTML] Generic sustained release tablets of trimetazidine hydrochloride: preparation and in vitro–in vivo correlation studies

L Wang, R Feng, J Gao, Y Xi, G Huang - asian journal of pharmaceutical …, 2016 - Elsevier
The aim of the current work was to develop generic sustained-release tablets containing 35
mg trimetazidine dihydrochloride and to establish an in vitro–in vivo correlation that could …

Design and evaluation of glimepiride hydrogel for transdermal delivery

H Li, J Wang, Q Xu, S Tian, W Yang - Drug Development and …, 2022 - Taylor & Francis
The solubility of glimepiride (GM) was improved from 1.6 μg/mL to 22.0 mg/mL when GM
and meglumine (MU) complexes were prepared. Therefore, transdermal hydrogels of GM …

IVIVC assessment, pharmacokinetic evaluation, and X-ray radiography mapping of Novel Parteck® SRP 80 and hypromellose-loaded LTD4 receptor antagonist …

S Jawed, CS Satish - Future Journal of Pharmaceutical Sciences, 2023 - Springer
Background The current research aims to determine the pharmacokinetic parameters,
mucoadhesive strength, and IVIVC correlation of the novel chronotherapeutic drug delivery …

[PDF][PDF] SRP 80 and hypromellose-loaded LTD4 receptor antagonist chronosystem

S Jawed, CS Satish - Future, 2023 - fjps.springeropen.com
IVIVC assessment, pharmacokinetic evaluation, and X-ray radiography mapping of novel
Parteck® SRP 80 and hypromellose-loaded LT Page 1 Jawed and Satish Future Journal of …

Modified pH independent/time controlled explosion system (TES) for targeted drug delivery in the lower intestinal tract: Formulation and pharmacokinetic evaluation in …

RSE Elbatanony - Journal of Drug Delivery Science and Technology, 2019 - Elsevier
The current work aimed to formulate a modified pH independent/time controlled release
tablet for delayed drug delivery. The effect of different coating levels and polymer …

A Study on The Manufacturability of High Drug Load Minitablets

LS Jun - 2023 - search.proquest.com
The preparation of minitablets from feed powder with a high micronized drug load is
generally unattainable via direct compression due to its inherent cohesivity, high charging …